Just-Evotec Biologics and Sandoz Expand their Collaboration for Biosimilar
Shots:
-
Just-Evotec Biologics (Evotec’s biologics segment) & Sandoz have expanded their tech collaboration to develop & manufacture biosimilars. They have been in a multi-year tech collaboration since May 2023
-
Under the agreement, Just-Evotec will get payment for early scientific validation along with additional funding tied to milestones from 2025
-
Through the expanded collaboration, Just-Evotec will provide biosimilar to Sandoz from its new J.POD facility. Sandoz further gets long-term supply guarantees with significant reserved manufacturing capacity
Ref: Sandoz and Just-Evotec Biologics | Image: Sandoz and Just-Evotec Biologics
Related News:- Sandoz Entered into an Agreement with Just - Evotec Biologics to Develop and Manufacture Multiple Biosimilar
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Tags
A passionate content writer with expertise in delivering high-quality and engaging content, Dipanshu is a keen reader and a versatile writer. Dipanshu dedicatedly covers news ranging from biopharma, life sciences, biotech, and MedTech to diagnostics and animal health companies. He can be contacted at connect@pharmashots.com
